Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

2011 AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease[1]

Smoking

Class I
"1. 1. For all patients, the clinician should encourage 30 to 60 minutes of moderate-intensity aerobic activity, such as brisk walking, at least 5 days and preferably 7 days per week, supplemented by an increase in daily lifestyle activities (eg, walking breaks at work, gardening, household work) to improve cardiorespiratory fitness and move patients out of the least fit, least active high-risk cohort (Level of Evidence: B)"
"2. For all patients, risk assessment with a physical activity history and/or an exercise test is recommended to guide prognosis and prescription. (Level of Evidence: B)"
"3. The clinician should counsel patients to report and be evaluated for symptoms related to exercise.(Level of Evidence: C)"
Class IIa
"1. It is reasonable for the clinician to recommend complementary resistance training at least 2 days per week. (Level of Evidence: C)"

Blood pressure control

Lipid management

Physical activity

Goal: At least 30 minutes, 7 days per week (minimum 5 days per week)

Weight management

Goals: Body mass index: 18.5 to 24.9 kg/m2 Waist circumference: women <35 inches (<89 cm), men 40 inches (<102 cm)

Type 2 diabetes mellitus management

Antiplatelet agents/anticoagulants

Antiplatelet agents/anticoagulants cont’d

Renin-angiotensin-aldosterone system blockers

Blockers

Blockers cont’d

Influenza vaccination

Depression

Cardiac rehabilitation

  1. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update http://ac.els-cdn.com/S0735109711043567/1-s2.0-S0735109711043567-main.pdf?_tid=49947b56-9d3e-11e6-a5c0-00000aab0f6c&acdnat=1477680333_bca68af215739ff9481a8a528bdd9554 Accessed on October 28, 2016